epiderm.org

What It Is

Epiderm is an AI-powered skin lesion screening tool positioned for quick mobile screening and long-term tracking, rather than medical diagnosis. After users take a photo of a skin lesion, the app runs AI locally on the device and returns plain-English results, a confidence score, and suggested next steps within seconds—such as continuing to monitor it, scanning again in a few weeks, or seeing a doctor. The page currently says the product is launching in India and expanding globally, with a waitlist available.

Core Capabilities and Outputs

Its AI model is disclosed as MobileNetV2, trained on data from HAM10000. It can analyze 7 types of skin lesions, with a stated accuracy of 73%. The workflow includes guidance on shooting distance and lighting, offline image analysis, result explanations, and recommendations. The more valuable feature is change detection: the same lesion can be scanned over weeks or months, with the system automatically aligning images, comparing changes in size, shape, and color on a timeline, and alerting users when it detects changes worth showing to a doctor.

Privacy, Pricing, and Integrations

Epiderm’s biggest selling point is its privacy-first design: by default, photos stay on the phone, AI runs locally, and no server is involved. Data only leaves the device if the user actively chooses to share it. Users can explicitly consent to having scans used to improve the model, or decline and continue using the app. In terms of pricing, the page says core screening is free and that operations are supported through research partnerships; no paid plans are disclosed. API, SDK, hospital system integrations, and payment methods are not specified.

Pros, Cons, and Who It’s For

The advantages are its low barrier to entry, free access, offline capability, clear privacy boundaries, and explicit reminder that “screening is not diagnosis.” The drawbacks are also clear: 73% accuracy is not enough to support medical decision-making, and the page does not disclose clinical certification, regulatory approvals, device requirements, or an official launch date. Chinese-language support is not mentioned either. It is suitable for individual users who want to record skin changes and receive early reminders, but not as a diagnostic tool to replace a dermatologist.

Access in China and Alternatives

The page does not provide information on availability in mainland China, app stores, payment, or Chinese localization, so its China access status can only be assessed as unknown. If use in China is limited, alternatives include dermatology departments at domestic hospitals, text-and-image consultations via internet hospitals, or similar overseas apps such as SkinVision, Miiskin, and Aysa. In all cases, AI results should only be used as a reference for seeking medical care.